Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Qilu Pharmaceutical Achieved Staggering Sales of Bevacizumab of RMB1.8 Billion in 2020

PharmaSources/CaicaiMarch 04, 2021

Tag: Bevacizumab , sales , Qilu

PharmaSources Customer Service